These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 21546068)

  • 21. Limbic encephalitis associated with anti-GAD antibody and common variable immune deficiency.
    Akman CI; Patterson MC; Rubinstein A; Herzog R
    Dev Med Child Neurol; 2009 Jul; 51(7):563-7. PubMed ID: 19191828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amelioration of differentiation of dendritic cells from CVID patients by intravenous immunoglobulin.
    Bayry J; Lacroix-Desmazes S; Hermine O; Oksenhendler E; Kazatchkine MD; Kaveri SV
    Am J Med; 2005 Dec; 118(12):1439-40. PubMed ID: 16378810
    [No Abstract]   [Full Text] [Related]  

  • 23. Usual interstitial pneumonitis in a patient with common variable immunodeficiency.
    Walker JC; O'Connell MA; Pluss JL
    J Allergy Clin Immunol; 1997 Jun; 99(6 Pt 1):847-51. PubMed ID: 9215255
    [No Abstract]   [Full Text] [Related]  

  • 24. [Laboratory markers in hepatitis C virus infection in patients with antibody formation disorders treated with immunoglobulin preparations].
    Litzman J; Pejcochová J; Lokaj J
    Vnitr Lek; 1996 May; 42(5):324-6. PubMed ID: 8768290
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carimune NF Liquid is a safe and effective immunoglobulin replacement therapy in patients with primary immunodeficiency diseases.
    Berger M; Cunningham-Rundles C; Bonilla FA; Melamed I; Bichler J; Zenker O; Ballow M
    J Clin Immunol; 2007 Sep; 27(5):503-9. PubMed ID: 17479360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective deficits in blood dendritic cell subsets in common variable immunodeficiency and X-linked agammaglobulinaemia but not specific polysaccharide antibody deficiency.
    Yong PF; Workman S; Wahid F; Exley A; Webster AD; Ibrahim MA
    Clin Immunol; 2008 Apr; 127(1):34-42. PubMed ID: 18295543
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Higher Cardiovascular Risk in Common Variable Immunodeficiency and X-Linked Agammaglobulinaemia Patients.
    Vieira DG; Costa-Carvalho BT; Hix S; da Silva R; Correia MSG; Sarni ROS
    Ann Nutr Metab; 2015; 66(4):237-241. PubMed ID: 26183722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravenous gamma globulin administration to common variable immunodeficient women during pregnancy: case report and review of the literature.
    Schaffer FM; Newton JA
    J Perinatol; 1994; 14(2):114-7. PubMed ID: 8014693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Eczema and X-linked agammaglobulinaemia.
    Hunter HL; McKenna KE; Edgar JD
    Clin Exp Dermatol; 2008 Mar; 33(2):148-50. PubMed ID: 18076688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of subcutaneous IgPro20 in patients with primary immunodeficiency.
    Wasserman RL; Melamed I; Nelson RP; Knutsen AP; Fasano MB; Stein MR; Rojavin MA; Church JA
    Clin Pharmacokinet; 2011 Jun; 50(6):405-14. PubMed ID: 21553933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum interferon-gamma is associated with longitudinal decline in lung function among asthmatic patients: the Normative Aging Study.
    Litonjua AA; Sparrow D; Guevarra L; O'Connor GT; Weiss ST; Tollerud DJ
    Ann Allergy Asthma Immunol; 2003 Apr; 90(4):422-8. PubMed ID: 12722965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary hypogammaglobulinaemia: impaired lung function and body growth with delayed diagnosis and inadequate treatment.
    Björkander J; Bake B; Hanson LA
    Eur J Respir Dis; 1984 Oct; 65(7):529-36. PubMed ID: 6489487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibody response in common variable immunodeficiency.
    Al-Herz W; McGeady SJ
    Ann Allergy Asthma Immunol; 2003 Feb; 90(2):244-7. PubMed ID: 12602674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Humoral immunodeficiencies: conferred risk of infections and benefits of immunoglobulin replacement therapy.
    Gernez Y; Baker MG; Maglione PJ
    Transfusion; 2018 Dec; 58 Suppl 3(Suppl 3):3056-3064. PubMed ID: 30536429
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of Gammaplex(®) 5% in children and adolescents with primary immunodeficiency diseases.
    Melamed IR; Gupta S; Stratford Bobbitt M; Hyland N; Moy JN
    Clin Exp Immunol; 2016 May; 184(2):228-36. PubMed ID: 26696596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progression of Common Variable Immunodeficiency Interstitial Lung Disease Accompanies Distinct Pulmonary and Laboratory Findings.
    Maglione PJ; Overbey JR; Cunningham-Rundles C
    J Allergy Clin Immunol Pract; 2015; 3(6):941-50. PubMed ID: 26372540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety, efficacy and pharmacokinetics of a new 10% liquid intravenous immunoglobulin (IVIG) in patients with primary immunodeficiency.
    Wasserman RL; Church JA; Stein M; Moy J; White M; Strausbaugh S; Schroeder H; Ballow M; Harris J; Melamed I; Elkayam D; Lumry W; Suez D; Rehman SM
    J Clin Immunol; 2012 Aug; 32(4):663-9. PubMed ID: 22392046
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subcutaneous immunoglobulin infusion as an alternative to intravenous immunoglobulin.
    Radinsky S; Bonagura VR
    J Allergy Clin Immunol; 2003 Sep; 112(3):630-3. PubMed ID: 13679829
    [No Abstract]   [Full Text] [Related]  

  • 39. Common variable immunodeficiency: experience in Puerto Rico.
    Santaella ML; Font I; Disdier O
    P R Health Sci J; 2005 Mar; 24(1):7-10. PubMed ID: 15895871
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Intravenous immunoglobulin therapy].
    Mouthon L
    Rev Prat; 2005 May; 55(10):1049-56. PubMed ID: 16097244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.